Canntab Therapeutics Limited announces entrance into Nova Scotia market
by CM Staff
On August 15th, 2022, Canntab completed its first shipment of 5mg and 10mg THC InstaCann tablets to the NSLC, totaling 300 bottles of each SKU.
TORONTO — Canntab Therapeutics Limited, a manufacturer involved in cannabinoid and terpene blends in hard pill form, provided an update on its recent product delivery of our unique pharmaceutical cannabinoid solutions to the Nova Scotia Liquor Corporation (the NSLC).
On August 15th, 2022, Canntab completed its first shipment of 5mg and 10mg THC InstaCann tablets to the NSLC, totaling 300 bottles of each SKU. These products are now available on the NSLC’s online platform and will be available in their brick-and-mortar stores starting today, August 22nd, 2022.
“This is a continuation of our efforts to expand our sphere of influence across not only Ontario, but the rest of the Canadian provinces,” says Richard Goldstein, co-founder, CFO, and interim CEO. Mr. Goldstein continues, “while we have our online ecommerce store open for our medical patients, getting into more retail locations while also being listed with the NSLC’s online platform is another positive move for Canntab. We are leaders in the oral delivery system of cannabis in the market today.”
